本文選題：羌活藥材 + 羌活�。� 參考：《中國(guó)中藥雜志》2017年14期

【摘要】：羌活作為一種重要傳統(tǒng)中藥品種,目前為694個(gè)藥廠(chǎng)生產(chǎn)的262種中成藥原料,在整個(gè)中醫(yī)藥產(chǎn)業(yè)中具有顯著經(jīng)濟(jì)價(jià)值和社會(huì)價(jià)值,但其野生資源瀕危且尚未完全實(shí)現(xiàn)人工產(chǎn)業(yè)化栽培。該文在系統(tǒng)總結(jié)羌活藥材的用藥歷史與產(chǎn)業(yè)發(fā)展現(xiàn)狀分析的基礎(chǔ)上,系統(tǒng)闡述了羌活藥材資源分布、羌活生態(tài)適宜性、羌活種子生產(chǎn)、種苗繁育、規(guī)�；耘嗟犬a(chǎn)業(yè)化栽培的相關(guān)內(nèi)容,并提出實(shí)施羌活產(chǎn)業(yè)化過(guò)程中需關(guān)注的關(guān)鍵問(wèn)題及對(duì)策。
[Abstract]:As an important traditional Chinese medicine variety, Notopterygium Notopterygii has 262 kinds of raw materials of Chinese patent medicine produced by 694 pharmaceutical factories, which have significant economic and social value in the whole Chinese medicine industry. But its wild resources are endangered and have not been fully cultivated. On the basis of systematically summarizing the history of drug use and the present situation of industry development of Radix Notopterygii, the distribution of medicinal materials, ecological suitability, seed production and seedling breeding of Notopterygium Notopterygii were systematically described in this paper. The related contents of industrialized cultivation such as large-scale cultivation were put forward, and the key problems and countermeasures to be paid attention to in the process of industrialization of Notopterygium chinensis were put forward.
【作者單位】： 四川省中醫(yī)藥科學(xué)院;四川大學(xué)環(huán)境科學(xué)與工程系;中國(guó)醫(yī)學(xué)科學(xué)院北京協(xié)和醫(yī)學(xué)院藥用植物研究所;成都大學(xué)環(huán)境系;四川省中醫(yī)藥管理局;
【基金】：國(guó)家自然科學(xué)基金項(xiàng)目(81473311) 四川省中醫(yī)藥強(qiáng)省建設(shè)戰(zhàn)略研究項(xiàng)目(2016ZR0068) 四川省中醫(yī)藥管理局科技專(zhuān)項(xiàng)(2017Z003)
【分類(lèi)號(hào)】：F326.12;R288
，

本文編號(hào)：2006869